NSE: AJANTPHARM | BSE: 532331

Expensive Performer

Download real time

2717.35 3.25 (0.12%)

32.45% Gain from 52W Low

18,769 NSE+BSE Volume

NSE 24 Mar, 2025 10:15 AM (IST)

33,943

Market Cap

High in industry

0.4

Beta 1Year

Very Low volatility

Capacity Expansion

Ajanta Pharma to expand Pithampur liquid facility by 12 mn bottles/year with a capex of Rs 92 crore See details

Ajanta Pharma Ltd. News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Keep track of all breaking news and updates on Ajanta Pharma Ltd. from all sources in a single place.

Load latest

Is Ajanta Pharma Ltd. worth buying?

186 Votes:

Buy 76.88%

Sell 16.13%

Hold 6.99%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf